Covered recipient · General Payments record
JAN C WEBER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2024
$1,373.61
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $489.01 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $278.38 | 10 |
| E.R. Squibb & Sons, L.L.C. | $100.00 | 1 |
| Vanda Pharmaceuticals Inc. | $36.38 | 1 |
| ACADIA Pharmaceuticals Inc | $21.56 | 1 |
| GENZYME CORPORATION | $21.06 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.69 | 1 |
| Lilly USA, LLC | $13.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.25 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106316527 | CMS |
| ABBVIE INC. | $17.02 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106316529 | CMS |
| ABBVIE INC. | $20.33 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106316531 | CMS |
| ABBVIE INC. | $19.86 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106316533 | CMS |
| ABBVIE INC. | $34.81 | 03/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106316535 | CMS |
| ABBVIE INC. | $34.15 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106316537 | CMS |
| ABBVIE INC. | $44.63 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106316539 | CMS |
| ABBVIE INC. | $34.68 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106316541 | CMS |
| ABBVIE INC. | $28.98 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106316543 | CMS |
| ABBVIE INC. | $25.67 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106316545 | CMS |
| ACADIA Pharmaceuticals Inc | $21.56 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147997095 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.69 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118029450 | CMS |
| E.R. Squibb & Sons, L.L.C. | $100.00 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101392586 | CMS |
| GENZYME CORPORATION | $21.06 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139702499 | CMS |
| Lilly USA, LLC | $13.94 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135048512 | CMS |
| Vanda Pharmaceuticals Inc. | $36.38 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133926191 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.